CÔNG TY CỔ PHẦN DƯỢC PHẨM MEDBOLIDE

FLEPGO 100 REPORT AT CENTER FOR ANDROLOGY AND SEXUAL MEDICINE– VIETDUC UNIVERSITY HOSPITAL

On May 27, 2026, at Center For Andrology and Sexual Medicine of Viet Duc University Hospital, Medbolide Pharmaceutical JSC successfully organized the “Workshop Introducing FLEPGO 100 (Avanafil 100mg) – A Solution for Erectile Dysfunction and Treatment – Onset Within 15 Minutes After Ingestion” chaired by Assoc. Prof. Dr. Nguyen Quang.

At the seminar, Dr. Cao Dac Tuan discussed FLEPGO 100 and its efficacy in treating erectile dysfunction. Erectile dysfunction is currently the most common sexual disorder among men. It affects not only the patient’s physical and mental health but also their partner and the couple’s relationship. FLEPGO 100, containing the active ingredient Avanafil 100mg, is a new-generation PDE5 inhibitor that selectively and specifically inhibits PDE5 in penile erectile tissue, helping to:

  • Fastest onset of erection—within 15 minutes after taking the medication
  • Fewest side effects among PDE5 inhibitors
  • Twice the efficacy in treating erectile dysfunction compared to Sildenafil across all disease severity levels
  • Effective in patients with dyslipidemia, diabetes, hypertension, etc., and those who have failed other erectile dysfunction treatments
  • Good response in patients with severe erectile dysfunction and those who have undergone prostatectomy

Following the seminar, the doctors spoke highly of FLEPGO 100 and expressed their hope for successful treatment of men with erectile dysfunction. Medbolide Company would like to extend its gratitude to the doctors and looks forward to continuing to partner with Center For Andrology and Sexual Medicine of Viet Duc University Hospital in providing effective treatment solutions and improving patients’ quality of life.

Readers comments